EVLO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.02%

Insider Buying (Last 12 Months): $12,499,999.05

Insider Selling (Last 12 Months): $78,917.36

Evelo Biosciences Insider Trading History Chart

Evelo Biosciences Share Price & Price History

^$0.05

▲ +0.01 (25.00%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Evelo Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2023	Marella Thorell	CFO	Sell	1,811	$0.33	$597.63	22,259
11/8/2023	Mark Bodmer	Insider	Sell	3,163	$0.33	$1,043.79	25,732
11/8/2023	Simba Gill	CEO	Sell	172	$0.33	$56.76	17,758
9/28/2023	Simba Gill	CEO	Sell	1,996	$3.94	$7,864.24	16,758
8/8/2023	Marella Thorell	CFO	Sell	2,004	$9.51	$19,058.04	9,069
8/8/2023	Mark Bodmer	Insider	Sell	3,128	$9.51	$29,747.28	16,624
8/8/2023	Simba Gill	CEO	Sell	342	$9.51	$3,252.42	3,754
7/11/2023	Ventures Fund Iv Gene Flagship	Major Shareholder	Buy	5,411,255	$2.31	$12,499,999.05	3,931,685
5/23/2023	Mark Bodmer	Insider	Sell	1,128	$2.80	$3,158.40	13,127
5/8/2023	Duncan Mchale	Insider	Sell	3,336	$2.60	$8,673.60	4,875
5/8/2023	Marella Thorell	CFO	Sell	1,926	$2.60	$5,007.60	4,573
5/8/2023	Simba Gill	CEO	Sell	176	$2.60	$457.60	2,925
1/23/2023	Stephen J Carriere	Insider	Sell	7	$21.20	$148.40	10
5/27/2022	Ventures Fund Iv Gene Flagship	Major Shareholder	Buy	1,369,862	$29.20	$39,999,970.40	684,931

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Evelo Biosciences (NASDAQ:EVLO)

0.31% of Evelo Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Evelo Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/1/2024	Vanguard Group Inc.	357,711	$1.40M	0.0%	+129.5%	1.885%
11/13/2023	FMR LLC	2,446,390	$9.59M	0.0%	+1,835.1%	12.923%
11/7/2023	Barclays PLC	11,755	$46K	0.0%	-87.4%	0.062%
8/11/2023	Credit Suisse AG	180,520	$0.18M	0.0%	-95.0%	3.224%
8/11/2023	BlackRock Inc.	53,539	$0.17M	0.0%	-95.4%	0.956%
8/11/2023	Geode Capital Management LLC	29,072	$94K	0.0%	-95.2%	0.519%
8/9/2023	Mayo Clinic	22,577	$73K	0.1%	-95.3%	0.403%
8/4/2023	Alphabet Inc.	53,024	$0.17M	0.0%	-95.0%	0.947%
8/3/2023	Barclays PLC	93,193	$0.30M	0.0%	+756.3%	0.495%
7/26/2023	State of Michigan Retirement System	203,536	$0.66M	0.0%	-95.0%	3.635%
5/16/2023	CVI Holdings LLC	840,577	$0.15M	0.1%	-42.9%	0.758%
5/12/2023	BlackRock Inc.	1,155,394	$0.21M	0.0%	-6.3%	1.042%
5/11/2023	FMR LLC	16,197,089	$2.93M	0.0%	-1.4%	14.601%
2/15/2023	Trustees of Columbia University in the City of New York	113,850	$0.18M	0.4%	N/A	0.105%
2/15/2023	Shay Capital LLC	18,511	$30K	0.0%	N/A	0.017%
2/15/2023	Millennium Management LLC	93,841	$0.15M	0.0%	-49.2%	0.087%
2/15/2023	Morgan Stanley	78,892	$0.13M	0.0%	+22.6%	0.073%
2/15/2023	Man Group plc	52,637	$85K	0.0%	N/A	0.049%
2/15/2023	Boothbay Fund Management LLC	52,699	$85K	0.0%	N/A	0.049%
2/14/2023	Susquehanna International Group LLP	146,059	$0.24M	0.0%	+549.9%	0.135%
2/14/2023	683 Capital Management LLC	90,291	$0.15M	0.0%	N/A	0.084%
2/13/2023	Barclays PLC	22,641	$36K	0.0%	+654.2%	0.021%
2/13/2023	Geode Capital Management LLC	607,443	$0.98M	0.0%	+3.6%	0.562%
2/10/2023	Bank of America Corp DE	19,279	$31K	0.0%	-60.4%	0.018%
2/9/2023	Mayo Clinic	479,242	$0.77M	0.4%	N/A	0.444%
2/9/2023	Citigroup Inc.	99,625	$0.16M	0.0%	+1,522.6%	0.092%
1/26/2023	Mayo Clinic	479,242	$0.77M	3.9%	N/A	0.444%
11/16/2022	Alphabet Inc.	1,060,495	$2.22M	0.1%	N/A	0.982%
11/15/2022	State Street Corp	113,858	$0.24M	0.0%	+20.9%	0.105%
11/15/2022	Vanguard Group Inc.	3,222,420	$6.74M	0.0%	+136.9%	2.984%
11/15/2022	BlackRock Inc.	1,205,366	$2.52M	0.0%	+32.3%	1.116%
11/14/2022	Ergoteles LLC	27,429	$57K	0.0%	-91.0%	0.025%
8/18/2022	Goldman Sachs Group Inc.	42,039	$89K	0.0%	-22.1%	0.078%
8/16/2022	CVI Holdings LLC	2,054,794	$4.34M	0.3%	N/A	3.829%
8/15/2022	State Street Corp	94,158	$0.20M	0.0%	-83.7%	0.175%
8/15/2022	Flagship Pioneering Inc.	50,427,328	$106.40M	4.0%	+119.0%	93.976%
8/15/2022	Millennium Management LLC	193,134	$0.41M	0.0%	+343.7%	0.360%
8/12/2022	Northern Trust Corp	72,135	$0.15M	0.0%	-74.9%	0.134%
8/12/2022	FMR LLC	16,185,709	$34.15M	0.0%	+101.2%	30.163%
8/8/2022	State of Michigan Retirement System	4,070,728	$8.59M	0.1%	+270.1%	7.586%
8/5/2022	abrdn plc	342,465	$0.72M	0.0%	N/A	0.638%
8/3/2022	AE Wealth Management LLC	56,029	$0.12M	0.0%	+78.2%	0.104%
6/7/2022	Bank of America Corp DE	16,165	$55K	0.0%	-52.9%	0.030%
5/27/2022	Walleye Capital LLC	11,180	$38K	0.0%	N/A	0.021%
5/17/2022	Walleye Capital LLC	11,180	$38K	0.0%	N/A	0.021%
5/16/2022	State Street Corp	578,861	$1.96M	0.0%	+3.3%	1.079%
5/16/2022	Cresset Asset Management LLC	30,000	$0.10M	0.0%	+200.0%	0.056%
5/13/2022	Northern Trust Corp	286,971	$0.97M	0.0%	-4.5%	0.535%
5/13/2022	Vanguard Group Inc.	1,544,518	$5.24M	0.0%	+9.4%	2.879%
5/12/2022	BlackRock Inc.	2,064,198	$7M	0.0%	-2.0%	3.847%
5/12/2022	Group One Trading L.P.	452,939	$1.54M	0.0%	+93.4%	0.844%
5/11/2022	GSA Capital Partners LLP	72,871	$0.25M	0.0%	N/A	0.136%
4/20/2022	Belvedere Trading LLC	172,792	$0.40M	0.0%	-28.3%	0.322%
4/18/2022	AE Wealth Management LLC	31,437	$0.11M	0.0%	+61.0%	0.059%
2/14/2022	Virtus ETF Advisers LLC	22,257	$0.14M	0.1%	+71.1%	0.042%
2/14/2022	Credit Suisse AG	3,566,487	$21.65M	0.0%	+7.7%	6.671%
2/11/2022	Alberta Investment Management Corp	40,000	$0.24M	0.0%	N/A	0.075%
2/8/2022	ProShare Advisors LLC	14,162	$86K	0.0%	N/A	0.026%
2/8/2022	Northern Trust Corp	300,436	$1.82M	0.0%	+0.8%	0.562%
2/3/2022	Larson Financial Group LLC	5,879	$36K	0.0%	-80.2%	0.011%
2/2/2022	New York State Common Retirement Fund	15,765	$96K	0.0%	+57.8%	0.029%
1/25/2022	Belvedere Trading LLC	241,137	$1.18M	0.1%	+75.1%	0.451%
1/20/2022	AE Wealth Management LLC	19,528	$0.12M	0.0%	+21.5%	0.037%
11/16/2021	Two Sigma Advisers LP	140,600	$0.99M	0.0%	+16.7%	0.263%
11/15/2021	Marshall Wace LLP	38,807	$0.27M	0.0%	-38.0%	0.073%
11/15/2021	GSA Capital Partners LLP	11,624	$82K	0.0%	N/A	0.022%
11/12/2021	The Manufacturers Life Insurance Company	10,483	$74K	0.0%	-43.5%	0.020%
11/12/2021	Credit Suisse AG	3,310,911	$23.31M	0.0%	+7.0%	6.193%
11/12/2021	Geode Capital Management LLC	520,717	$3.67M	0.0%	+10.3%	0.974%
11/10/2021	Goldman Sachs Group Inc.	38,492	$0.27M	0.0%	+43.7%	0.072%
11/10/2021	Citigroup Inc.	5,742	$40K	0.0%	+297.6%	0.011%
11/9/2021	Barclays PLC	12,412	$87K	0.0%	+223.0%	0.023%
11/9/2021	BlackRock Inc.	1,840,250	$12.95M	0.0%	-0.2%	3.442%
11/8/2021	State Board of Administration of Florida Retirement System	10,241	$72K	0.0%	N/A	0.019%
11/8/2021	Meeder Asset Management Inc.	8,858	$61K	0.0%	+82.4%	0.017%
11/4/2021	Deutsche Bank AG	36,952	$0.26M	0.0%	+81.8%	0.069%
11/4/2021	Larson Financial Group LLC	29,705	$0.21M	0.0%	-5.3%	0.056%
11/2/2021	New York State Common Retirement Fund	9,988	$70K	0.0%	-63.4%	0.019%
11/1/2021	AE Wealth Management LLC	16,077	$0.11M	0.0%	+14.1%	0.030%
11/1/2021	SG Americas Securities LLC	10,454	$74K	0.0%	N/A	0.020%
10/27/2021	State of Michigan Retirement System	1,100,000	$7.74M	0.0%	+22.2%	2.060%
10/19/2021	Belvedere Trading LLC	137,751	$1.13M	0.0%	-810.1%	0.258%
9/3/2021	Parametric Portfolio Associates LLC	22,216	$0.31M	0.0%	-21.3%	0.042%
8/25/2021	Marshall Wace LLP	62,602	$0.86M	0.0%	-58.2%	0.117%
8/17/2021	Metropolitan Life Insurance Co NY	8,937	$0.12M	0.0%	N/A	0.017%
8/17/2021	Millennium Management LLC	50,538	$0.69M	0.0%	-59.5%	0.095%
8/17/2021	MetLife Investment Management LLC	12,153	$0.17M	0.0%	N/A	0.023%
8/16/2021	AQR Capital Management LLC	13,092	$0.18M	0.0%	-72.6%	0.025%
8/16/2021	California State Teachers Retirement System	41,923	$0.58M	0.0%	+20.7%	0.079%
8/16/2021	Alberta Investment Management Corp	40,000	$0.55M	0.0%	N/A	0.075%
8/16/2021	Amundi	32,472	$0.45M	0.0%	N/A	0.061%
8/16/2021	Credit Suisse AG	3,095,719	$42.54M	0.0%	+3.6%	5.797%
8/16/2021	Charles Schwab Investment Management Inc.	192,181	$2.64M	0.0%	+12.8%	0.360%
8/16/2021	State Street Corp	489,781	$6.73M	0.0%	+52.3%	0.917%
8/16/2021	Nuveen Asset Management LLC	108,406	$1.49M	0.0%	+63.0%	0.203%
8/16/2021	Goldman Sachs Group Inc.	26,779	$0.37M	0.0%	+90.4%	0.050%
8/16/2021	Marshall Wace LLP	62,602	$0.86M	0.0%	-58.2%	0.117%
8/13/2021	Northern Trust Corp	322,651	$4.43M	0.0%	+26.6%	0.604%
8/13/2021	OLD Mission Capital LLC	10,061	$0.14M	0.0%	N/A	0.019%
8/13/2021	Geode Capital Management LLC	472,138	$6.49M	0.0%	+22.4%	0.884%

Data available starting January 2016

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $0.05

$0.05

50 Day Range

MA: $0.05

$0.04

$0.06

52 Week Range

Now: $0.05

$0.03

$13.93

Volume

1,555 shs

Average Volume

43,202 shs

Market Capitalization

$949,000.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Who are the company insiders with the largest holdings of Evelo Biosciences?: Evelo Biosciences' top insider shareholders include:
Ventures Fund Iv Gene Flagship (Major Shareholder)
Mark Bodmer (Insider)
Marella Thorell (CFO)
Simba Gill (CEO)
Duncan Mchale (Insider)
Stephen J Carriere (Insider)
Learn More about top insider investors at Evelo Biosciences.